ReviewDiabetology & metabolic syndrome2026

Empagliflozin's role in cardiometabolic disease treatment: an Egyptian expert's view.

Samir H Assaad-Khalil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.